Tidal Investments LLC Acquires 46,215 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Tidal Investments LLC boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1,422.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 49,465 shares of the biotechnology company’s stock after purchasing an additional 46,215 shares during the period. Tidal Investments LLC’s holdings in Axon Enterprise were worth $29,398,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Vanguard Group Inc. raised its position in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the period. Geode Capital Management LLC raised its position in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock valued at $1,095,542,000 after purchasing an additional 65,097 shares during the period. Capital World Investors raised its position in shares of Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock valued at $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. raised its position in shares of Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after purchasing an additional 812,337 shares during the period. Finally, Norges Bank bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $482,081,000. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the sale, the president now owns 308,714 shares in the company, valued at $210,947,363.34. The trade was a 2.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 23,764 shares of company stock worth $14,856,635 over the last 90 days. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 0.7%

Shares of AXON stock opened at $733.18 on Friday. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $735.68. The firm’s fifty day simple moving average is $584.61 and its 200 day simple moving average is $594.51. The firm has a market capitalization of $57.08 billion, a P/E ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the company earned $1.15 earnings per share. The business’s revenue was up 31.3% compared to the same quarter last year. As a group, sell-side analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on AXON shares. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research report on Wednesday. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research report on Friday, May 9th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $652.73.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.